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Abstract
Paracoccidioidomycosis (PCM), caused by Paracoccidioides species is a prevalent sys-
temic and progressive mycosis that occurs in Latin America. It is caused by Paracocci-
dioides species. Immunization with dendritic cells transfected with a plasmid encoding the
scFv (pMAC/PS-scFv) that mimics the main antigen of P. brasiliensis (gp43) confers protec-
tion in experimental PCM. DCs link innate and adaptive immunity by recognizing invading
pathogens and selecting the type of effector T cell to mediate the immune response. Here,
we showed that DC-pMAC/PS-scFv induces the activation of CD4+ and CD8+ T cells. More-
over, our results demonstrated that BALB/c mice infected with P. brasiliensis and treated
with DC-pMAC/PS-scFv showed the induction of specific IgG production against gp43 and
IFN-γ, IL-12 and IL-4 cytokines. Analysis of regional lymph nodes revealed increases in the
expression of clec7a,myd88, tlr2, gata3 and tbx21, which are involved in the immune re-
sponse. Taken together, our results indicate that the scFv modulates the humoral and cellu-
lar immune responses and presents epitopes to CD4+ and CD8+ T cells.
Introduction
Paracoccidioidomycosis (PCM) is an important mycotic disease in Latin America caused by
species of the genus Paracoccidioides. Both the Paracoccidioides brasiliensis (P. brasiliensis) and
P. lutzii species are thermally dimorphic. Infection is initiated through the inhalation of fungal
conidia and a primary attack of lung tissues [1].
The innate and adaptive immune responses to PCM have been investigated using several ex-
perimental models. The protective immune response has been associated with high levels of
IFN-γ and IL-2, while the non-protective immune response has been correlated with increased
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IL-4 production [2]. Toll-like receptors (TLR) play a role in innate immunity and are crucial to
the pathogenic process. Dendritic cells (DCs) are the most effective antigen-presenting cells for
inducing cell-mediated immune responses. The interaction between P. brasiliensis and pulmo-
nary DCs induces IL-10 production and TLR-2 expression, which has been suggested to be a
possible mechanism of susceptibility to PCM [3].
The main and most well-characterized antigenic component of P. brasiliensis is a 43-kDa
glycoprotein (gp43) [4]. Previous research has shown that the immunization of mice with anti-
gp43 monoclonal antibodies (Ab1) initiates the idiotypic cascade proposed by Jerne and in-
duces both anti-idiotype (anti-Id) (Ab2 α and β) and anti-anti-Id (Ab3) antibody production
[5]. The Ab2 mAb 7.B12 inhibits more than 95% of the binding of gp43 to Ab1, suggesting that
this mAb represents the internal image of gp43, as proposed by Nesonoff and Lamoyi [6].
In 2004, a T cell proliferative response was demonstrated following the immunization of
mice with an Ab2-βMab (7.B12) and their subsequent exposure to gp43 in vitro, indicating
that this molecule contains a T cell epitope [7, 8]. However, the use of this antibody can cause
damage to the host due to its size and induction of an unspecific immune response.
The peptide P10 of gp43 from P. brasiliensismodulates the immune response. After P10
plasmid immunization, a stronger protective immune response involving a CD4+ T cell epitope
has been observed [8]. DNA vaccination has shown therapeutic effects in experimental PCM
based on a reduction in fungal burden [9–11].
Previous studies by our group [12] have suggested that a single-chain variable fragment
(scFv) that mimics the Ab2-β 7.B12 Mab against gp43 may decrease the yeast cell burden in
the lungs of infected mice when it is transfected into dendritic cells (DC-pMAC/PS-scFv). An-
tibody fragments are currently the most variable proteins that can be employed as therapeutic,
diagnostic, and research tools, and they have the largest worldwide market among pharmaceu-
tical proteins [13,14].
The use of transfected DCs carrying inserts is very important in the modulation of infection,
and because they have been shown to be efficient in the control of experimental PCM [12], the
present study addresses the role of DCs transfected with scFv in modulatory functions in the
innate and adaptive immune responses.
Our data further confirm that these transfected cells seem to play an important role during
the infection of mice with P. brasiliensis, as determined by the capacity of the activated immune
system. Here, we have shown that pMAC/PS-scFv induces the high expression of CCR7+/
CD40+ molecules in DCs and that the scFv contains epitopes of both CD4+ and CD8+ T cells,
an important aspect in the protection against PCM.
Materials and Methods
1. Mice and ethics statement
Female BALB/c mice (8–12 weeks) were housed under pathogen-free conditions at the animal
laboratory facility of the University of São Paulo. The Committee on the Ethics of Animal Ex-
periments of the University of São Paulo approved the protocol in 08/2011 (Permit Number:
321). In the infection experiments, the animals were anesthetized using intraperitoneal keta-
mine (80–100 mg/kg) in combination with xylazine. The mice were euthanized by carbon
dioxide overdose.
2. Paracoccidioides brasiliensis strain
The yeast forms of the highly virulent P. brasiliensis strain 18 (Pb18) were grown on Sabouraud
agar (Becton, Dickinson and Company, Le Pont de Claix, France) and were used for the
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infection assays. The viability of the yeast cells was determined using trypan blue. We used cell
populations with viabilities of higher than 90%.
3. Antigen
The purification of gp43 from an exoantigen of P. brasiliensis B-339 was prepared as previously
described [15]. Gp43 glycoprotein was quantified using the Bradford method [16] and used at
a concentration of 20 μg/mL.
4. Migratory DCs and T cell profiles
To detect migrating DCs and activated T cells, BALB/c mice were immunized in the thigh by
the intramuscular injection of 20μg/mL pMAC/PS-scFv. As a control, we used 20 μg/mL of
empty vector (pMAC/PS) or 20 μL of PBS. After 7 days, inguinal and popliteal lymph node
cells were obtained and analyzed by flow cytometry with a FACSCanto II (Becton Dickinson).
To determine the expression of MHC class II and co-stimulatory molecules in the DCs, we
used labeled mAbs against mouse PE CD11c (N418), FITC CD8a (Ly2 53–6.7), FITC DEC-205
(NLDC-145) and PE CD40 (3/23). To determine the T cell profiles, we used labeled Mabs
against mouse APC CD3e (145-2C11), PE CD3e (145C11), FITC CD4 (L3T4 6K 1.5), APC
CD8a (53–6.7) and PE-Cy5 FoxP3 (FJK-16s) (all antibodies were obtained from BD Biosci-
ences, San Jose, CA). The flow cytometry data were analyzed using FlowJo. Fluorescence-
minus-one (FMO) tubes were used as additional controls.
5. Gene expression analysis
To analyze the gene expression in inguinal and popliteal lymph node cells, the animals were
immunized via the intramuscular route, as described above. After one week, lymph node cells
were obtained, and total RNA was extracted using TRIzol (Invitrogen). PCR was performed ac-
cording to the manufacturer’s instructions. The total RNA was reverse-transcribed to cDNA
using RT2 qPCRMaster Mix (Qiagen Company) and amplified with SYBR Green. PCR was
performed with an ABI7500 real-time PCR instrument (Applied Biosystems). The data were
analyzed using software version 1.3. The transcription profiles of the following genes were
studied: clec7a, gata3, tbx21, tlr2, tlr4 andmyd88. The PPC,MGDC, RTC, Gapdh and B2m
housekeeping genes were used as assay controls. The calculation was done using 2-ΔΔCT and
statistical analysis was conducted on average expression values obtained from three separate
experiments.
6. T cell epitope prediction







used the Immune Epitope Database Program (IEDB analysis resource). This program provides
a collection of tools for the prediction and analysis of immune epitopes. We used a T cell epi-
tope prediction tool that includes MHC class I and II binding predictions, as well as peptide
processing predictions.
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For this study, we used the following BALB/c mouse alleles: H2-IAd and H2-IEd for MHC
class II and H2-Dd, H2-Kd and H2-Ld for MHC class I. The selected MHC class II epitope had
an IC50 of<500 nm, corresponding to an intermediate affinity, and the chosen MHC class I
epitope had an IC50 of<50 nm, corresponding to a higher affinity.
7. Proliferation assay
To evaluate T cell proliferation, inguinal and popliteal lymph node cells were isolated from
BALB/c mice after intramuscular immunization with PBS (20μL), empty vector (20 μg/mL) or
pMAC/PS-scFv (20 μg/mL). The total cells from lymph nodes (3x105) were cultivated in RPMI
1640 medium containing 10% fetal bovine serum plus 20 μg/mL of gp43 antigen. They were
then stained with 5(6)-carboxyfluorescein diacetate N-succinimidyl ester (CFSE). After 72 h,
lymphoproliferation was analyzed by flow cytometry. Concanavalin (ConA) mitogen was used
as a positive control.
8. Enrichment of DCs
Bone marrow-derived DCs were generated as previously described [17]. Femurs and tibias
were flushed with 3–5 ml of PBS with 1% BSA. Bone marrow cells were allowed to differentiate
into DCs via culturing in RPMI (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10%
fetal calf serum (FCS) (Cultilab, Brazil), 10 μg/mL gentamicin (Schering-Plough, USA), and re-
combinant cytokine GM-CSF (50 ng/mL) (Peprotech, Brazil) for 7 days. On days 3 and 5, non-
adherent cells (granulocytes and lymphocytes) were removed, and the media and growth fac-
tors were replaced. On day 7, non-adherent cells were removed and analyzed by FACS using
DC cell surface markers. More than 90% of the cells were CD11c+MHC class II+ (data not
shown).
9. Transfection of DCs with pMAC/PS-scFv
Bone marrow-derived DCs (2x105) were transfected with pMAC/PS-scFv (20 μg/mL) using
JetPEI Macrophage (Polyplus Transfection). DCs transfected with an empty vector were used
as a control (pMAC/PS). The empty pMAC/PS vector and the vector encoding the scFv were
obtained as previously described [12].
10. Co-stimulatory molecules in transfected DCs
The effects of DC transfection with pMAC/PS-scFv, the empty vector or the PBS control on
DC surface molecule expression were investigated. Phenotypes were analyzed by flow cytome-
try. To identify the MHC class II and co-stimulatory molecules, labeled Mabs against mouse
I-A, CD11c, CD80, CD86 and CD40 were used. FlowJo was used for flow cytometry data analy-
ses, and FMO tubes were used as additional controls.
11. BALB/c therapy
Mice were challenged with an intratracheal inoculation of 1x106 Pb18 yeast cells [18]. The
mice were divided into four groups, and after 7 and 14 days, they received therapeutic doses of
the following via intramuscular injection: 1) PBS only (50 μL); 2) DCs only (1x106 cells); 3)
DCs transfected with pMAC/PS (1x106 cells transfected with 20 μg/mL of vector) and 4) DCs
transfected with pMAC/PS-scFv (1x106 cells transfected with 20 μg/mL of vector containing
scFv). To determine the types of cells activated in the lung, after 21 days of infection, all ani-
mals were euthanized. The lungs were removed, and the lung cell phenotypes were examined
by flow cytometry. To determine the expression levels of several molecules of interest, we used
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labeled Mabs against mouse FITC or PE CD11c (N418), FITC CD4 (L3T4 6K 1.5), PE CD3e
(1452C11), APC CD8a (53–6.7), PE CCR7 (4B12) and FITC CD40 (3/23) (all antibodies were
obtained from BD Bioscience, San Jose, CA). FlowJo was used for analyses of flow cytometry
data, and FMO tubes were used as additional controls [19].
12. Measurement of cytokines
Cytokine production was analyzed in the lung and regional lymph node, subsequent to the
BALB/c therapy. After 21 days of infection, all mice were sacrificed, and the lungs and medias-
tinal and axillary lymph nodes were removed. The homogenate was filtered in sterile gauze and
centrifuged at 1400 x g at 4°C for 10 min, and the supernatants were assayed for IL-12, IL-4
and IFN-γ by ELISA (BD).
13. IgG production
Total IgG, and IgG1 and IgG2a isotype production were analyzed at 7 days after the first and
second immunizations. Serum samples were obtained via bleeding from the tail vein and stored
at -20°C until use. An ELISA for IgG anti-gp43 was performed as previously described, with
minor modifications [12]. Briefly, polystyrene microplates (Costar, Cambridge, MA) were
coated with gp43 (20 μg/mL), diluted in 0.1 M carbonate-bicarbonate buffer (pH 9.6), incubat-
ed at 37°C for 1 h, and stored at 4°C overnight. The plates were washed with phosphate-buff-
ered saline (PBS), blocked with a solution containing PBS, 0.05% gelatin, and 2% bovine serum
albumin, and incubated for 1 h at 37°C. After the plates were washed with PBS + 0.1% Tween,
50 μL of different mouse serum dilutions were added and incubated for 2 h at 37°C. The plates
were washed, and an anti-mouse peroxidase monoclonal antibody (Southern Biotechnology,
Birmingham, AL) diluted 1:25 in PBS + 0.01% gelatin + 0.4% bovine serum albumin was added
and incubated for 1 h at 37°C. Horseradish peroxidase-streptavidin (1:1000, Genzyme, Cam-
bridge, MA) was added for 30 min and incubated at 37°C. The reaction was developed with
50 μL tetramethylbenzidine (TMB) (Organon Teknika, the Netherlands) diluted 1:1 with urea
peroxide for 10 min. The reaction was stopped with 2 N H2SO4, and optical densities (OD)
were measured at 450 nm with an ELISA reader (Bio-Rad, Hercules, CA). The same steps were
followed for the IgG1 and IgG2a subclasses, the result shown is the ratio of IgG2a to IgG1.
14. Statistics
Prism 5 (GraphPad Inc.) was used for all statistical analyses. The data were compared using ei-
ther two-way analysis of variance (ANOVA) followed by Bonferroni’s multiple comparison
tests or ANOVA followed by the Tukey-Kramer test [20]. All data are represented as the mean
and standard deviation (SD).
Results
1. Immunization with pMAC/PS-scFv results in increases in CD4+ T cell
and DC numbers in lymph nodes
T cells and DCs are important in the PCM immune response. To assess the ability of pMAC/
PS-scFv to activate these cells, BALB/c mice were immunized with this molecule by the intra-
muscular route. After a week, total lymph node cells were collected, and the phenotypes were
analyzed by flow cytometry. As expected, the mice immunized with pMAC/PS-scFv exhibited
increases in CD11c+/CD8+ and CD11c+/CD40+ DCs, but we did not observe an alteration in
the DEC-205 phenotype (Fig 1A). Therefore, the high expression of CD3e/CD4+ was also
observed in the pMAC/PS-scFv-immunized mice compared with the PBS-immunized mice
scFv Modulate Cellular and Humoral Response in Paracoccidioidomycosis
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(Fig 1B). pMAC/PS-scFv has been shown to induced specific alterations in PCM that are not
observed following pMAC/PS treatment [12], although both treatments resulted in the same
level of CD3e/CD4+ expression (Fig 1B). No significant differences were observed in CD3e/
CD8+ expression (Fig 1C).
2. Analysis of lymph node gene expression profiles after immunization
with pMAC/PS-scFv
Several genes have been shown to play important roles in the immune response. To determine
whether pMAC/PS-scFv alters the expression of these genes, we performed PCR to analyze sev-
eral genes that are involved in the innate (tlr2, tlr4,myd88 and clec7) and adaptive (tbx21 and
gata3) immune responses. The results showed significant increases in clec7, gata3,myd88,
Fig 1. Phenotype of DCs and T cells. BALB/c mice (seven/group) were immunized via intramuscular injection of PBS, pMAC/PS or pMAC/PS-scFv. After 7
days the lymph nodes were obtained and the DCs CD11c+/CD8+, CD11c+/CD40 and CD11c+/DEC205 (A) and CD4+ (B) and CD8+ (C) T cells were analyzed
by flow cytometer. *p<0.05. A. Flow cytometry graph: one representative experiment is shown. B and C: Data are expressed as the number of cells obtained
with specific Ab. Results are representative of three independent experiments.
doi:10.1371/journal.pone.0129401.g001
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tbx21 and tlr2 expression in regional lymph nodes at 7 days after immunization with pMAC/
PS-scFv compared with PBS control immunization. We observed the higher expression of
gata3, tbx21 and tlr4 in the empty vector group compared with the PBS control group. Howev-
er, when we compared the construct (pMAC/PS-scFv) group with the empty vector (pMAC/
PS) group, we observed increases in clec7a andmyd88 expression (Fig 2).
3. Epitopes to CD4+ and CD8+ cells
Antigenic peptides displayed by MHC class II and MHC class I molecules are crucial for the ac-
tivation of CD4+ and CD8+ cells, respectively. To determine whether pMAC/PS-scFv can be
displayed by MHC class I or MHC class II molecules, we analyzed the possible epitopes respon-
sible for activating these cells. The MHC class II H2-IAd binding prediction results revealed
the presence of 2 peptides with IC50 values of<500 nm that were 15 amino acids in length
(aa): TISSMEAEDAATYYC and ISSMEAEDAATYYCH. In contrast, the MHC class I H2-Kd
binding prediction results revealed the following 3 peptides with high affinities (IC50<50
nm): AYISSAGSYI (10 aa), WYFDVWGTGTTV (12 aa) and SYSLTISSM (9 aa). MHC class II
H2 IE-d, MHC class I H2-Dd, and MHC class I H2-Ld showed lower predicted affinities.
To determine whether these predictions were in accordance with the observed T cell activa-
tion, 7 days after intramuscular immunization of the BALB/c mice with pMAC/PS-scFv, we
collected regional lymph nodes and cultivated the cells in the presence of gp43. We observed
Fig 2. Gene expression. After intramuscular immunization in BALB/c mice (seven/group) with PBS, pMAC/PS or pMAC/PS-scFv, total RNA from lymph
nodes was extracted and the gene expression were analyzed by PCR array. (A) clec7a; (B) tlr2; (C) tlr4; (D)myd88; (E) gata3 and (F) tbx 21. *p<0.05 and
**p<0.001. Results are representative of three independent experiments.
doi:10.1371/journal.pone.0129401.g002
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the very specific proliferation of CD4+ (Fig 3A) and CD8+ T cells (Fig 3B) in the pMAC/PS-
scFv-immunized mice compared with the control mice and the pMAC/PS-immunized mice.
4. DCs transfected with pMAC/PS-scFv do not show altered molecular
expression profiles
DCs transfected with pMAC/PS-scFv provide important protection against PCM; therefore, we
analyzed whether the transfection process could induce the expression of molecules involved
in antigen presentation as well as co-stimulatory molecules on the surfaces of DCs. FACS anal-
ysis was conducted after 24 h, which was the duration of mouse immunization. At this time
point, the DCs were transfected with pMAC/PS-scFv, and the expression levels of MHC class
II and co-stimulatory molecules were analyzed. Interestingly, we did not observe any differ-
ences in MHC class II, CD80, CD40 or CD86 expression compared with the controls (DCs or
DCs transfected with an empty vector) (Fig 4).
5. Effects of transfected DCs on T cell activation and migration of DCs
To determine whether DCs transfected with pMAC/PS-scFv were capable of stimulating T
cells and inducing a migratory DC phenotype, BALB/c mice were intratracheally infected with
Pb18 yeast. On days 7 and 14, the animals were treated as described in the Materials and Meth-
ods section. At one week after the last treatment, the lungs were collected, and the total cells
were labeled with anti-CD3/CD4, anti-CD3/CD8 and anti-CCR7/CD40. As expected, we ob-
served a higher population of CD4+ and CD8+ T cells after the DC-pMAC/PS-scFv treatment
compared with the PBS or DC control treatment (Fig 5A and 5B, respectively); however, no
differences were observed in the CD4+ or CD8+ T cells following the DC-pMAC/PS treatment
compared with the DC-pMAC/PS-scFv treatment. Additionally, we observed the increased ex-
pression of the migration-related protein CCR7/CD40+ (Fig 5C). Although DC-pMAC/PS-
scFv did not induce antigen presentation or co-stimulatory molecule expression, a migratory
phenotype was observed, suggesting that DC-pMAC/PS-scFv migrated from the lungs to the
lymph nodes, where it presented the antigen to T cells through MHC class I and MHC class
II molecules.
Fig 3. CD4+ and CD8+ T cells activation. Lymph node cells from seven BALB/c mice per group were obtained after intramuscular immunization with PBS,
pMAC/PS or pMAC/PS-scFv. 3x105 cells were cultivated with 20 μg/mL of gp43 antigen. After that, the cells were stained with CFSE and after 72 hours,
lymphoproliferation of CD4+ (A) and CD8+ (B) was analyzed by flow cytometry. As a positive control, we used concanavalin mitogen (ConA). *p<0.05.
Results are representative of three independent experiments.
doi:10.1371/journal.pone.0129401.g003
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6. DCs transfected with pMAC/PS-scFv modulate cytokine production
Cytokines, such as IFN-γ, IL-12 and IL-4, are important proteins during fungal infection. To
analyze cytokine production, lymph nodes or lung cells were obtained from untreated controls
or BALB/c mice that were previously infected with PB18 yeast and treated with DCs trans-
fected with pMAC/PS-scFv. The cells were cultivated in vitro for 24 h, and supernatants were
collected and evaluated for IFN-γ, IL-4 and IL-12 cytokine production. Our results indicated
significant increases in all of the cytokines analyzed in the lymph node cells (Fig 6A), although
these cytokines were down-regulated in the lung cells (Fig 6B) compared with the BALB/c
mice that received PBS only or DCs transfected with an empty vector (controls).
7. BALB/c therapy with DCs transfected with pMAC-PS-scFv induces
IgG2a production
To determine whether DCs transfected with pMAC/PS-scFv induce a humoral response, seven
days after each of the treatments, serum samples were obtained from the BALB/c mice and an-
alyzed for the total IgG, IgG1 and IgG2a isotypes. We used a specific antigen (20 μg/mL of
gp43) to measure the IgG levels against experimental PCM. We observed an increase in IgG
production (Fig 7A) in the sera from the BALB/c mice that received the treatment compared
with those in the PBS and control groups. Analysis of the IgG isotypes revealed that the DC-
pMAC/PS-scFv treatment induced an increase in IgG2a and a decrease in IgG1 compared with
the control treatments (DCs transfected with empty vector or PBS only). A significant increase
in the IgG2a/IgG1 ratio was observed in the sera of the mice treated with DC-pMAC/PS-scFv
compared with those of the mice treated with DC-pMAC/PS (Fig 7B).
Discussion
P. brasiliensis is responsible for one of the most common fungal infections in Latin America.
Thus, the need to develop a novel immunotherapeutic model for this infection is of great im-
portance to public health.
In recent decades, various researchers have attempted to develop an anti-PCM therapy, and
clinical trials have achieved modest results. Single-chain variable fragment (scFv) antibodies
have emerged as an option for passive immunotherapy [21]. J591-scFv, which recognizes the
Fig 4. DCsmolecule expression.DCs were transfected with pMAC/PS-scFv. After 48 hours the total DCs were stained with anti-MHCII/CD11c, anti-CD86,
anti-CD40 and anti-CD80. The data were analyzed by flow cytometer. Results are representative of three independent experiments.
doi:10.1371/journal.pone.0129401.g004
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extracellular glycoprotein prostate-specific membrane antigen, has been constructed and can
be used in diagnostic and targeted therapeutic applications [22]. KT-scFv is effective against
Candida albicans rat vaginal infections [23,24]. Additionally, an scFv containing genes encod-
ing capsular polysaccharides provides protection against Neisseria meningitides [25]. There-
fore, the understanding of the mechanisms of action of scFvs and their modulation of immune
function is crucial for developing new therapies. In this investigation, we used an scFv from
Ab2-β of the gp43 protein of P. brasiliensis that confers protection against PCM [12]. We as-
sessed the induction of specific T cell responses. Additionally, we analyzed DCs transfected
Fig 5. Phenotype of lung cells. BALB/c mice (seven/group) were infected with P. brasiliensis yeast (1x106). After that, the animals received twice treatments
with PBS (50μL), DC (1x106), DC-pMAC/PS (1x106 cells plus 20ng/mL DNA) and DC-pMAC/PS-scFv (1x106 cells plus 20ng/mL DNA). After seven days
from the last treatment, the lung cells were stained with anti-CD3e/CD4 (A), anti-CD3e/CD8 (B) and anti-CD40/CCR7 (C). As control of the infection, BALB/c
mice received only PBS (50μL) by intratracheal pathway. The data was analyzed by flow cytometer. Flow cytometry graphs: one representative experiment
is shown.
doi:10.1371/journal.pone.0129401.g005
Fig 6. Cytokines. BALB/c mice (seven/group) were infected with 1x106 of P. brasiliensis yeast. On 7 and 14
days, the animals were treateds with pMAC/PS-scFv. As control, the BALB/c mice was treateds with PBS
(50μL) or empty vector. After seven days of last burst, the lung (A) and lynph nodes (B) cells were cultivated
in vitro for 24 hours and the IFN-γ, IL-12 and IL-4 were measured by ELISA. *p<0.05 e **p<0,001. Results
are representative of three independent experiments.
doi:10.1371/journal.pone.0129401.g006
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with this scFv with respect to antigen presentation, cell migration and their ability to efficiently
induce a therapeutic effect in experimental PCM.
First, we studied the T cells and molecules activated in lymph nodes from BALB/c mice that
were immunized with pMAC/PS-scFv. Our work suggests that APCs are capable of recognizing
scFv in the thigh muscle and migrate to regional lymph nodes, where they induce increases in
CD11c+/CD8+ and CD11c+/CD40 cells and also stimulate the proliferation of CD4+ and CD8+
T cells.
CD4+ T cells receive a signal from APCs, usually DCs, for activation. CD40L, which is al-
ready expressed on activated CD4+ T cells, engages with the CD40 that is up-regulated on acti-
vated DCs upon PAMP recognition [26,27]. Moreover, CD8α+ DCs present antigens on both
MHC class II and MHC class I molecules. These cells also have the ability of cross-presenta-
tion, whereby an extracellular antigen is taken up and presented on MHC class I molecules to
CD8+ T cells [28].
These results were confirmed using a lymphoproliferation assay against gp43, a specific an-
tigen of P. brasiliensis, which showed CD4+ and CD8+ T cell stimulation. In addition, analysis
of the presentation pathways using the IEDB analysis program revealed that the scFv sequence
is predicted to stimulate both MHC class II and class I presentation, in agreement with the lym-
phoproliferation assay. It is important to note that only the DCs transfected with pMAC/PS-
scFv was able to stimulate CD8+ and CD4+ T cell proliferation, demonstrating a specific role of
the scFv in contrast with the empty vector. Transfection of the DCs with the empty vector and
pMAC/PS-scFv showed similar results. This finding may have been due to the induction of a
non-specific immune response by the SV40 tag that is present in scFv construction.
Some studies have shown the importance of CD4+ and CD8+ T cells in PCM. One such
study has shown that both CD4+ and CD8+ T cells provide protection against pulmonary
PCM, but the relative protection of susceptible mice is mainly mediated by CD8+ T cells [29].
Considering the importance of the innate and adaptive immune responses in PCM protec-
tion, we analyzed several genes known to be involved in recognition, phagocytosis and lympho-
cyte activation. Our results showed an increase in gata3 and tbx21 expression, which could be
involved in a variety of Th1/Th2 immune responses. Moreover, we observed increased levels of
clec7a,myd88 and tlr2 gene expression in lymph node cells from immunized BALB/c mice.
Taken together, our results suggest that DCs transfected with pMAC/PS-scFv could induce
dectin-1, Myd88 and TLR2 expression in the initiation of the innate immune response.
Fig 7. Humoral response. BALB/c mice (seven/group) were infected previously with P. Brasiliensis yeast (1x106) by intratracheal pathway. The animals
were treateds twice with pMAC/PS-scFv and total IgG was measured (A). The ratio between IgG2a/IgG1 was analyse (B) *p<0.05. Results are
representative of three independent experiments.
doi:10.1371/journal.pone.0129401.g007
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Additionally, dectin-1 was able to recognize endogenous ligands in T cells, thereby inducing
MHC cross-presentation [30]. Therefore, we postulate that the increase in clec7a expression
may be involved in CD8+ T cell antigen-specific activation through the Myd88 adapter mole-
cule. In addition to TLR2, other TLRs, such as TLR4, have been implicated in the innate recog-
nition of fungal infection [31]. There has been increasing interest in the uses of both Toll/TIR
and CLR ligands as adjuvants to enhance vaccine efficacy [32].
The activation of either T cell subset was contingent upon the nature of the fungal therapy,
the involvement of distinct innate receptor signaling pathways, and the mode of antigen rout-
ing and presentation in the DCs.
DCs are an attractive therapeutic target because they are an essential link between the innate
and adaptive immune responses; therefore, we examined the participation of these cells transfected
with pMAC/PS-scFv in the control of P. brasiliensis infection. We have shown that transfected
DCs control infection and are responsible for decreasing the fungal burden in the lungs of treated
mice [10]. However, the mechanisms involved in PCM protection have been unknown until now.
The transfection process in DCs occurs by endocytosis and can alter surface molecules, but we
did not observe a significant difference in surface molecule expression. After being treated with
the DCs transfected with pMAC/PS-scFv, the infected mice showed increases in the CCR7/
CD40+ DC population and in the activation of CD4+ and CD8+ T cells in the lung. Similar results
were observed in lymph node cells from the BALB/c mice immunized by the intramuscular route
without transfection. Mouse resistance to PCM is associated with concomitant CD4+ and CD8+
T cell immunity [29]. In Aspergillus fumigatus infection, both CD4+ and CD8+ T cells mediate
vaccine-induced protection from experimental aspergillosis [32]. Moreover, we observed higher
CCR7 expression in the DCs, which is necessary for their migration to T cell-populated areas in
secondary lymphoid tissues [33] and for efficient signaling to T cells by CD40L [26,27].
T cell activation depends on cytokine production. The cytokine profiles detected in the lung
and lymph node cell cultures of the mice treated with pMAC/PS-scFv showed a mixture of
Th1/Th2 immune responses. Although the lungs showed decreases in IFN-γ, IL-12 and IL-4,
we observed increases in these cytokines in the regional lymph nodes after the treatment. The
primary site of PCM is lung tissue; however, after the recognition of the fungus by DCs, these
cells migrate to secondary lymphoid organs, where they are activated and induce cytokine pro-
duction, leading to T cell activation.
The DCs transfected with pMAC/PS-scFv induced a humoral response. We demonstrated
specific IgG production against gp43. Interestingly, analysis of the immunoglobulin switch
showed an increase in IgG2a after the second treatment but a reduction in IgG1 against the
same glycoprotein.
In agreement with our results, Martins and colleagues have demonstrated the predominance
of IgG1 over IgG2a in sera collected at 30 days after challenge with radioattenuated yeast of P.
brasiliensis in BALB/c mice. In contrast, in sera collected at 90 days after challenge, the higher
production of IgG2a compared with IgG1 has been reported [34].
In conclusion, the present study has revealed that pMAC/PS-scFv immunization or treatments
using transfected DCs induce primed CD4+ and CD8+ T cells in vivo. Furthermore, our work sug-
gests that genetic engineering is capable of inducing cross-presentation and modulating the cellu-
lar and humoral immune responses that could induce protection to P. brasiliensis-infected mice.
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